A public product site and private beta
The public site explains PEPRA's appearance-analysis product, methods, privacy practices and operating boundaries. The iPhone app is being tested before public App Store release.
Explore the preview →Company / 01
PEPRA is an appearance and wellness software product developed and operated by Toliman AI LLC. The company is building private, inspectable tools that help adults decide what to try next.
The record / 02
The public site explains PEPRA's appearance-analysis product, methods, privacy practices and operating boundaries. The iPhone app is being tested before public App Store release.
Explore the preview →Toliman AI LLC does not currently operate a clinician network, pharmacy, laboratory, sequencing service or medical practice. Planned partners and clinical pathways remain labeled as planned.
Read the clinical boundary →James Baker is co-founder and CEO of Toliman AI LLC and the point of contact for PEPRA product, research, privacy and partnership questions.
Operating principles / 03
These are design requirements, not launch copy. They determine what PEPRA may connect, infer, display, and hand off.
A polished interface cannot make a weak signal strong. PEPRA is being designed to preserve provenance, uncertainty, and the limits of what the underlying evidence can support.
A future data pathway must be permitted by the source, deliberately authorized by the person, and limited to what the product actually needs.
Educational interpretation does not become medical care through better graphics. Any future clinical pathway must be independently operated under separate terms.
PEPRA will describe the product that exists—not the company, partnerships, integrations, or outcomes it hopes to build later.
Accountability / 04
PEPRA's next stage is not unlocked by a date or announcement. It is unlocked only when the relevant product, permission, privacy, security, evidence, and operating conditions are real.
Review every gate